Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.

Caroline ToschBérangère BastienLuc BarraudBenoit GrellierVirginie NourtierMurielle GantzerJean Marc LimacherEric QuemeneurKaïdre BendjamaXavier Préville

Published in: Journal for immunotherapy of cancer (2017)

Registered on ClinicalTrials.gov under identifier NCT01383148 on June 23rd, 2011.

Keyphrases

immune response
small cell lung cancer
sars cov
advanced non small cell lung cancer
dendritic cells
toll like receptor